Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / HSP90B1

HSP90B1

Basics

Aliases:
This biomarker is also known as:
  • heat shock protein 90kDa beta (Grp94), member 1,
  • 94 kDa glucose-regulated protein,
  • tumor rejection antigen (gp96) 1,
  • tumor rejection antigen 1,
  • GP96,
  • Heat shock protein 90 kDa beta member 1,
  • GRP-94,
  • GRP94,
  • endothelial cell (HBMEC) glycoprotein,
  • TRA1,
  • gp96 homolog,
  • heat shock protein 90 kDa beta member 1,
  • ECGP,
  • stress-inducible tumor rejection antigen gp96,
  • endoplasmin,
  • Tumor rejection antigen 1,

View in BioMuta

Description…

heat shock protein 90kDa beta (Grp94), member 1

Attributes

QA State: Under Review
Type: Gene
Short Name:

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Announcement 09/14/2014

Thank you to everyone who helped make the 9th EDRN Scientific Workshop a success. We look forward to seeing everyone at the 28th EDRN Steering Committee Meeting from March 31-April 2, 2015, in Atlanta, GA.

Announcement 06/05/2014


Funding Opportunity Available

Both RFAs for Molecular and Cellular Characterization of Screen-Detected Lesions have been published.

RFA-CA-14-010.html

and

RFA-CA-14-011.html